IDUN PHARMACEUTICALS INC — Form D/A
IDUN PHARMACEUTICALS INC of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2015-02-04. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-02-04
- Form: D/A
- Accession: 0001140361-15-004099
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $2.0M
- Minimum investment: $1
- Investors: 30
- Date of first sale: 2014-02-13
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-212450
Issuer
- Name: IDUN PHARMACEUTICALS INC
- CIK: 0001076413
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 12463 RANCHO BERNARDO RD., #554, SAN DIEGO, CA, 92128
- Phone: 858-756-2480
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| David F Hale | Director | San Diego, CA |
| David F Hale | Executive Officer | San Diego, CA |
| Harold O Van Wart, Ph.D. | Director | SAN DIEGO, CA |
| Marc O Perret | Director | SAN DIEGO, CA |
| James O Scopa | Director | SAN DIEGO, CA |
| Shahzad F Malik | Director | San Diego, CA |
| Paul F Klingenstein | Director | San Diego, CA |
| William F Gerber, M.D. | Director | San Diego, CA |
| Steven J Mento, Ph.D. | Director | San Diego, CA |
| Louis F Lacasse | Director | San Diego, CA |
Other filings by this issuer (3)
More